A website to provide support for people who have or have had any type of cancer, for their caregivers and for their family members.
Page 2 of 2 FirstFirst 12
Results 11 to 15 of 15

Thread: Anybody else in here have Refractory (terminal) AML??

  1. #11
    Actually, I understand where the doctors are coming from. If you're going to do a major cancer clinical study, you're talking about hundreds of patients, an expenditure of millions of dollars, and 4 - 7 years of the doctor's life to do the study. Once the exclusion criteria are established, you cannot change the study protocol for any reason. If you do, the study no longer meets the basic standards of scientific rigor and clinical control that are required for a valid clinical protocol, and no medical journal or society will touch a flawed study with a 10 foot pole. The study will never get published or recognized, and no drug company will bet hundreds of millions of dollars of its own money trying to sell a "flawed" cure.
    Last edited by Dead Man Walking; 07-16-2017 at 06:30 PM.
    05/6/16 pre-op physical for surgery show low WBC & RBC
    5/22/16 [Birthday] Results of BM biopsy: AML 25% blasts with inv t(3:3) mutation, HIGH risk
    5/30/16 Undergo 3+7 chemo, but it doesn't touch AML, infections nearly kill me. Blasts 65%
    7/04/16 Diagnosis now Refractory AML. [:tombstone:]Six cycles of azacitidine, 21 shots over 7 days w/ 1.5" needle into gut + below navel.
    11/05/16 Move to NOLA - Infusion center 4 minutes away. 15 shots for 5 days with 5/8" 25 ga. needle Huge increase in quality of life.
    12/28/16 BMB shows blasts 12%
    4/16/17 BMB shows CD34 16%, cycles dropped to 4 weeks
    7/20/17 Diagnosis changed to "indolent leukemia", aka MDS
    7/27/17 BMB shows CD34 17%
    8/15/17 Venclexta chemo in PILL form added Onc estimates survival time now 2 - 4 YEARS.
    10/26/17 BMB results show 17/20 metaphases with inv(3:3) mutation-low blood cell counts - transfusions ineffective
    12/4/17 Diagnosis: Uncontrolled refractory AML

  2. #12
    Moved to separate post....
    Last edited by Dead Man Walking; 07-29-2017 at 03:23 PM.
    05/6/16 pre-op physical for surgery show low WBC & RBC
    5/22/16 [Birthday] Results of BM biopsy: AML 25% blasts with inv t(3:3) mutation, HIGH risk
    5/30/16 Undergo 3+7 chemo, but it doesn't touch AML, infections nearly kill me. Blasts 65%
    7/04/16 Diagnosis now Refractory AML. [:tombstone:]Six cycles of azacitidine, 21 shots over 7 days w/ 1.5" needle into gut + below navel.
    11/05/16 Move to NOLA - Infusion center 4 minutes away. 15 shots for 5 days with 5/8" 25 ga. needle Huge increase in quality of life.
    12/28/16 BMB shows blasts 12%
    4/16/17 BMB shows CD34 16%, cycles dropped to 4 weeks
    7/20/17 Diagnosis changed to "indolent leukemia", aka MDS
    7/27/17 BMB shows CD34 17%
    8/15/17 Venclexta chemo in PILL form added Onc estimates survival time now 2 - 4 YEARS.
    10/26/17 BMB results show 17/20 metaphases with inv(3:3) mutation-low blood cell counts - transfusions ineffective
    12/4/17 Diagnosis: Uncontrolled refractory AML

  3. #13
    Newbie New User
    Join Date
    Jan 2018
    Posts
    7
    I'm in same boat. I need some advice, I'm 36 years old have AML M4 I think. I've done 7+3 induction didn't work, then High dose Cytarabine didn't work. Then even 2nd line MEC still didn't work, my brother is stem cell match but Dr at ucla says can't do stem cell transplant unless I achieve remission, he said there's no more chemo to try. I feel good even after all I been through. I'm having to get platelet transfusions twice a week though. Any ideals would be great, thanks.

  4. #14
    There are two things you can try: One is azacitidine injections 3x per day for 5 days with a shot of neulasta the next Monday.. You repeat this every 4th calendar week. It kept me in pretty good shape for about 14 months, and them my AML mutated into a more refractory form of the disease so that didn't work any more. Right now I am on a combination of venclexta, which is a pill (yay!), and LOW dose cytabarine injections in the gut. This has been labeled a breakthrough treatment by the FDA and they fast-tracked it. I have also been trying to wean myself of those damn transfusions, and it's been a battle. In a meeting with my Oncologist last Friday, however, she said that they have had two other patients with nasty case of AML like I have, and with the Venclexta and cytabarine they both achieved full remission in two months flat!! That's kind of mind boggling, but it's real world data.

    I'm 68, and the azacitidine has been shown to be more effective than the standard 3+7 for us old geezers, so that's one data point. From a comfort standpoint, the Venclexta pills and 1 shot in the gut each day for two weeks is better by far than 15 shots in the gut every 4th week. The other thing I should note is that none of the chemo I have had ever made me puke, or even feel queasy. Based on my mutations, I'm a 1%'er, so my journey is somewhat unique.

    The other thing that might be possible is that some cancer cells are associated with a certain genetic enzyme, and if you have this enzyme, then a treatment can be set up so that it attacks ONLY the cancer cells, so you can get a very high kill ratio for a given dose of chemo.

    I hope some of this may be of value to you, and my best wishes that you break the back of the monster..

    DMW
    05/6/16 pre-op physical for surgery show low WBC & RBC
    5/22/16 [Birthday] Results of BM biopsy: AML 25% blasts with inv t(3:3) mutation, HIGH risk
    5/30/16 Undergo 3+7 chemo, but it doesn't touch AML, infections nearly kill me. Blasts 65%
    7/04/16 Diagnosis now Refractory AML. [:tombstone:]Six cycles of azacitidine, 21 shots over 7 days w/ 1.5" needle into gut + below navel.
    11/05/16 Move to NOLA - Infusion center 4 minutes away. 15 shots for 5 days with 5/8" 25 ga. needle Huge increase in quality of life.
    12/28/16 BMB shows blasts 12%
    4/16/17 BMB shows CD34 16%, cycles dropped to 4 weeks
    7/20/17 Diagnosis changed to "indolent leukemia", aka MDS
    7/27/17 BMB shows CD34 17%
    8/15/17 Venclexta chemo in PILL form added Onc estimates survival time now 2 - 4 YEARS.
    10/26/17 BMB results show 17/20 metaphases with inv(3:3) mutation-low blood cell counts - transfusions ineffective
    12/4/17 Diagnosis: Uncontrolled refractory AML

  5. #15
    Super Moderator Top User po18guy's Avatar
    Join Date
    Feb 2012
    Posts
    9,003
    Has this one been mentioned, just in case?

    [URL="http://www.bloodjournal.org/content/126/23/3090?sso-checked=true"]http://www.bloodjournal.org/content/126/23/3090?sso-checked=true

    [url]https://www.clinicaltrials.gov/ct2/results?cond=AML&term=ALT-803&cntry=&state=&city=&dist=[/url]
    [/URL]
    07/08 Age 56 DX 1) Peripheral T-Cell Lymphoma-Not Otherwise Specified. Stage IV-B, >50 ("innumerable") tumors, bone marrow involvement.
    08/08-12/08 Four cycles CHOEP14 + four cycles GND (Cyclofosfamide, Doxorubicin, Vincristine, Etoposide, Prednisone & Gemcitabine, Navelbine, Doxil)
    02/09 2) Relapse.
    03/09-06/13 Clinical trial of Romidepsin > long-term study. NED for 64 twenty-eight day cycles, dose tapered.
    07/13 3) Relapse, 4) Suspected Mutation.
    08/13-02/14 Romidepsin increased, stopped for lack of response. Watch & Wait.
    09/14 Relapse/Progression. Visible cervical nodes appear within 4 days of being checked clear.
    10/06/14 One cycle Belinostat. Discontinued to enter second clinical trial.
    10/25/14 Clinical trial of Alisertib/Failed - Progression.
    01/12/15 Belinostat resumed/Failed - Progression. 02/23/15
    02/24/15 Pralatrexate/Failed - Progression. 04/17/15
    04/15 Genomic profiling reveals mutation into PTCL-NOS + AngioImmunoblastic T-Cell Lymphoma. Stage IV-B a second time. Two dozen tumors + small intestine (Ileum) involvement.
    04/22/15 TREC (Bendamustine, Etoposide, Carboplatin). Full response in two cycles. PET/CT both clear. Third cycle followed.
    06/15-07/15 Transplant preparation (X-rays, spinal taps, BMB, blood test, MUGA scan, lung function, CMV screening, C-Diff testing etc. etc. etc.) Intrathecal Methotrexate during spinal tap.
    BMB reveals 5) 26% blast cells of 20q Deletion Myelodysplastic Syndrome MDS), a bone marrow cancer.
    07/11-12/15 Cyclofosfamide + Fludarabine conditioning regimen.
    07/16/15 Total Body Irradiation.
    07/17/15 Moderate intensity Haploidentical Allogeneic Stem Cell Transplant receiving my son's peripheral blood stem cells.
    07/21-22/15 Triple dose Cyclofosfamide + Mesna, followed by immunosuppressants Tacrolimus and Mycophenolate Mofetil.
    07/23-08/03/15 Marrow producing zero blood cells. Fever. Hospitalized two weeks.
    08/04/15 Engraftment occurs, and blood cells are measureable - released from hospital.
    08/13/15 Day 26 - Marrow is 100% donor cells. Platelets climbing steadily, red cells follow.
    09/21/15 Acute skin Graft versus Host Disease arrives.
    DEXA scan reveals Osteoporosis.
    09/26/-11/03/15 Prednisone to control skin GvHD.
    11/2015 Acute GvHD re-classified to Chronic Graft versus Host Disease.
    05/2016 Tacrolimus stopped. Prednisone from 30-90mg daily tried. Sirolimus begun.
    09/16/16 Three skin punch biopsies.
    11/04/16 GvHD clinical trial of Ofatumumab (Arzerra) + Prednisone + Methylprednisolone begun.
    12/16 Type II Diabetes, Hypertension - both treatment-related.
    05/17 Extracorporeal Photopheresis (ECP) begun in attempt to control chronic Graft-versus-Host-Disease (cGvHD.
    05/2017 Chronic anemia (low hematocrit). Chronic kidney disease.
    06/17 Trying various antibiotics in a search for tolerable prophylaxis.
    08/17 Bone marrow biopsy reveals the presence of 2% cells with 20q Deletion Myelodysplastic Syndrome, considered to be Minimum Residual Disease.
    12/17 Bone marrow biopsy reveals no abnormalities in the marrow - MDS eradicated. The steroid taper continues.
    01/18 Consented for Kadmon clinical trial of drug KD025, a ROCK2 inhibitor that is believed to help with chronic GvHD.
    03/18 Began 400mg daily of KD025, a rho-Associated Coiled-coil Kinase 2 Inhibitor (ROCK2).
    To date: 18 chemotherapeutic drugs in 9 regimens (4 of them at least twice), 5 salvage regimens, 4 clinical trials, 4 post-transplant immuno-suppressant drugs, the equivalent of 1,000 years of background radiation from scanning from 45+ CT series scans and about 24 PET scans. Having had both lymphoid and myeloid malignancies lend a certain symmetry to the journey.

    Believing in the redemptive value of suffering makes all the difference.

 

Similar Threads

  1. Friend with refractory AML
    By Mary Z in forum Leukemia/Myelodysplastic Syndrome Forum
    Replies: 5
    Last Post: 08-19-2016, 06:20 AM
  2. Anybody else have problems with Levoquin (Levofloxicin) antibiotic?
    By Emiliee in forum Lymphoma - Hodgkin's and Non-Hodgkin's Lymphoma Forum
    Replies: 0
    Last Post: 08-10-2013, 05:09 AM
  3. How Terminal is Terminal???
    By MsJenx in forum Colon Cancer and Rectal Cancer Forum
    Replies: 6
    Last Post: 06-01-2011, 03:27 AM
  4. Does anybody else have problems ?
    By edyak in forum Colon Cancer and Rectal Cancer Forum
    Replies: 1
    Last Post: 02-25-2010, 08:58 PM
  5. Anybody out there with M4, t(6;9) AML?
    By sammac in forum Leukemia/Myelodysplastic Syndrome Forum
    Replies: 9
    Last Post: 06-27-2009, 11:51 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •